Literature DB >> 3055195

Mesophilic aeromonads in human disease: current taxonomy, laboratory identification, and infectious disease spectrum.

J M Janda1, P S Duffey.   

Abstract

The importance of the genus Aeromonas in human disease has recently become better appreciated through the use of improved methodologies for the recovery and identification of aeromonads from biologic specimens and as a result of medical studies aimed at determining the clinical significance of these bacteria when isolated from localized and invasive infections of humans. Taxonomic schemes currently allow for the identification of six Aeromonas species (five mesophilic and one psychrophilic), four of the five mesophilic species having been recovered from infectious processes or isolated from clinical material of human origin. Two major categories of human illness attributed to Aeromonas species have been observed: acute gastroenteritis in both pediatric and adult populations and disseminated disease (e.g., bacteremia) in persons with underlying hematologic malignancies or hepatic dysfunctions. Although the role of mesophilic aeromonads as important agents of bacterial gastroenteritis remains unconfirmed because of the inability to fulfill Koch's postulates (no animal model), several lines of compelling clinical and laboratory evidence indicate that these microorganisms are significant enteric pathogens.

Entities:  

Mesh:

Year:  1988        PMID: 3055195     DOI: 10.1093/clinids/10.5.980

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  64 in total

1.  Identification of motile Aeromonas strains with the MicroScan WalkAway system in conjunction with the combo negative type 1S panels.

Authors:  J Vivas; A I Sáa; A Tinajas; L Barbeyto; L A Rodríguez
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

2.  Electrophoretic analysis of the surface components of autoagglutinating surface array protein-positive and surface array protein-negative Aeromonas hydrophila and Aeromonas sobria.

Authors:  R P Kokka; N A Vedros; J M Janda
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

3.  Aeromonas hydrophila blepharoconjunctivitis.

Authors:  J M Sire; P Ropert; P Y Donnio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

4.  Aeromonas jandaei and Aeromonas veronii dual infection of a human wound following aquatic exposure.

Authors:  S W Joseph; A M Carnahan; P R Brayton; G R Fanning; R Almazan; C Drabick; E W Trudo; R R Colwell
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

5.  Aeromonas jandaei (formerly genospecies DNA group 9 A. sobria), a new sucrose-negative species isolated from clinical specimens.

Authors:  A Carnahan; G R Fanning; S W Joseph
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

6.  Analysis of the autoagglutination phenomenon, serogroup and hydrophobicity as virulence markers in mesophilic aeromonads isolated from stool cultures.

Authors:  J Reina; I Llompart; J Gomez; N Borrell; A Serra; P Alomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

Review 7.  Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas.

Authors:  J M Janda
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

8.  The genus Aeromonas: biochemical characteristics, atypical reactions, and phenotypic identification schemes.

Authors:  Sharon L Abbott; Wendy K W Cheung; J Michael Janda
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 9.  Aeromonas hydrophila myonecrosis accompanying mucormycosis five years after bone marrow transplantation.

Authors:  A E Moses; M Leibergal; G Rahav; M Perouansky; R Or; M Shapiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

10.  Diarrhea and intestinal invasiveness of Aeromonas strains in the removable intestinal tie rabbit model.

Authors:  G Pazzaglia; R B Sack; A L Bourgeois; J Froehlich; J Eckstein
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.